These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6567480)

  • 21. Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study.
    Hori K; Zhang QH; Saito S; Tanda S; Li HC; Suzuki M
    Cancer Res; 1993 Nov; 53(22):5528-34. PubMed ID: 8221694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of angiotensin II on blood flow in tumours during localized hyperthermia.
    Maeta M; Karino T; Inoue Y; Hamazoe R; Shimizu N; Koga S
    Int J Hyperthermia; 1989; 5(2):191-7. PubMed ID: 2926185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor microcirculation and selective enhancement of drug delivery--clinical applications based on pathophysiological experiments].
    Sato H; Hori K; Sugiyama K; Tanda S; Sato Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1191-200. PubMed ID: 10945016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on angiotensin-induced hypertension chemotherapy (IHC)].
    Sato H; Hoshi M; Wakui A
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1439-47. PubMed ID: 3729461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cancer chemotherapy in combination with angiotensin-induced hypertension].
    Wakui A; Suzuki M
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1577-83. PubMed ID: 6409008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II.
    Burton MA; Gray BN; Self GW; Heggie JC; Townsend PS
    Cancer Res; 1985 Nov; 45(11 Pt 1):5390-3. PubMed ID: 4053012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of systemically applied angiotensin II on the microcirculation of glomerular capillaries in the rat.
    Zimmerhackl B; Parekh N; Kücherer H; Steinhausen M
    Kidney Int; 1985 Jan; 27(1):17-24. PubMed ID: 3981870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs.
    Kerr DJ; Goldberg JA; Anderson JR; Wilmott N; Whatelely AT; McArdle CS; Mckillop J
    EXS; 1992; 61():339-45. PubMed ID: 1617236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the tooth eruption and regional blood flow in angiotensin II-induced hypertensive rats.
    Shimada A; Shibata T; Komatsu K
    Arch Oral Biol; 2004 Jun; 49(6):427-33. PubMed ID: 15099799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs.
    Hansen TN; Le Blanc AL; Gest AL
    J Appl Physiol (1985); 1985 Mar; 58(3):812-8. PubMed ID: 3980386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of endothelin on the renal microcirculation of the split hydronephrotic rat kidney.
    Fretschner M; Endlich K; Gulbins E; Lang RE; Schlottmann K; Steinhausen M
    Ren Physiol Biochem; 1991; 14(3):112-27. PubMed ID: 1707547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive drugs and tumor blood flow.
    Peterson HI; Mattson J
    Biorheology; 1984; 21(4):503-8. PubMed ID: 6487762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nitric oxide synthesis blockade and angiotensin II on blood flow and spontaneous vasomotion in the rat cerebral microcirculation.
    Morita-Tsuzuki Y; Bouskela E; Hardebo JE
    Acta Physiol Scand; 1993 Aug; 148(4):449-54. PubMed ID: 8213199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of angiotensin II and other noradrenergic vasoconstrictors on the blood flow in Yoshida rat ascites hepatoma AH 109 A at same electrode position].
    Li YL; Hori K; Saito S; Tanda S; Suzuki M
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):548-53. PubMed ID: 1969726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of tumor blood flow: a review.
    Jain RK
    Cancer Res; 1988 May; 48(10):2641-58. PubMed ID: 3282647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride.
    Hori K; Saito S; Takahashi H; Sato H; Maeda H; Sato Y
    Jpn J Cancer Res; 2000 Feb; 91(2):261-9. PubMed ID: 10761715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of arginine vasopressin on cerebral microvascular pressure.
    Faraci FM; Mayhan WG; Schmid PG; Heistad DD
    Am J Physiol; 1988 Jul; 255(1 Pt 2):H70-6. PubMed ID: 3394828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of chemotherapy under angiotensin II-induced hypertension in patients with advanced cancer.
    Yamaue H; Tanimura H; Terashita S; Iwahashi M; Tani M; Tsunoda T; Tamai M; Mori K
    Nihon Geka Hokan; 1990 Jul; 59(4):302-9. PubMed ID: 2130794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of tumour blood flow using the hypertensive agent, angiotensin II.
    Tozer GM; Shaffi KM
    Br J Cancer; 1993 May; 67(5):981-8. PubMed ID: 8494732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced hypertension chemotherapy for solid tumors based on functional characteristics of tumor vessels.
    Wakui A; Suzuki M
    Jpn J Med; 1985 Feb; 24(1):77-8. PubMed ID: 3999467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.